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Abstract The 4.5 million organic molecules with up to
20 non-hydrogen atoms in PubChem were analyzed using
the MQN-system, which consists in 42 integer value
descriptors of molecular structure. The 42-dimensional
MQN-space was visualised by principal component anal-
ysis and representation of the (PC1, PC2), (PC1, PC3) and
(PC2, PC3) planes. The molecules were organized
according to ring count (PC1, 38% of variance), the
molecular size (PC2, 25% of variance), and the H-bond
acceptor count (PC3, 12% of variance). Compounds fol-
lowing Lipinski’s bioavailability, Oprea’s lead-likeness
and Congreve’s fragment-likeness criteria formed sepa-
rated groups in MQN-space visible in the (PC2, PC3)
plane. MQN-similarity searches of the 4.5 million mole-
cules (see the browser available at www.gdb.unibe.ch)
gave significant enrichment factors for recovering groups
of fragment-sized bioactive compounds related to ten dif-
ferent biological targets taken from Chembl, allowing lead-
hopping relationships not seen with substructure fingerprint
similarity searches. The diversity of different compound
series was analyzed by MQN-distance histograms.
Keywords PubChem  Fragments  Chemical space 
Virtual screening
Introduction
In fragment-based drug discovery one starts by screening a
few thousand fragment-sized molecules for weak bioac-
tivity [1–8]. The fragment selection is critical since it
should cover a relevant structural diversity. This selection
would be facilitated if a simple overview of the known
chemical space was available [9]. Herein we report an
analysis and visualisation of the 4.5 million fragment-sized
molecules currently reported in the public access database
PubChem [10] using the MQN-system.
The MQN-system classifies organic molecules using 42
integer value descriptors of molecular structure including
classical topological indexes such as atom and ring counts,
and a few additional counts such as cyclic and acyclic
unsaturations, atoms and bonds in fused rings, and elec-
trostatic charges predicted for neutral pH (Table 1) [11].
We call these descriptors molecular quantum numbers
(MQNs) in analogy to the atomic and principal quantum
numbers classifying the elements in the periodic system
[12]. The 42 MQNs form a 42-dimensional chemical space.
Since the MQNs only have integer values, MQN-space is
composed of ‘‘MQN-bins’’ to which molecules are
assigned if they share the same MQN values. Such MQN-
isomers may be compared to isotopes sharing the same
atomic and principal quantum number in the periodic
system of the elements.
A chemical space is created whenever molecules are
described by a series of values collected in a vector or
fingerprint, each value defining a separate dimension [13].
Among the various approaches reported sofar to represent
chemical space [14–16], MQN-space has the advantage of
simplicity. For instance chemical spaces have been con-
structed by assigning dimensions to descriptors such
as eigenvalues of matrices constructed from primary
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descriptors [13, 17, 18], or more directly to descriptors of
molecular structure and calculated physicochemical prop-
erties [19, 20], or by using various types of fingerprints
[21]. These descriptor sets are obtained from the molecular
structures through complex and partly machine-controlled
calculations, which renders the immediate understanding of
the resulting chemical space inaccessible to non-specialists.
By contrast the MQN-dimensions correspond to values
which can be counted in a structural formula by anyone
having basic training in organic chemistry. In this manner,
the link between the strutural formula of a compound and
its position in MQN-space is self-explanatory. Further-
more, MQN-calculations are extremely fast and therefore
particularly well suited to classify very large databases
such as PubChem, which contains over 20 million struc-
tures, or the chemical universe database GDB-13 which
contains 977 million structures as shown in the following
paper in this issue [22–25]. The MQN-system is also rel-
evant for medicinal chemistry, as illustrated by the fact that
similarity searches in MQN-space enrich bioactives in the
DUD database [26] from the entire PubChem with effi-
ciencies comparable to that of substructure fingerprints,
with the added benefit that lead-hopping relationships
between actives are allowed [27].
The following paper details the MQN-analysis of the
fragment subset of PubChem comprising all molecules
with up to 20 non-hydrogen atoms (hac B 20), which
corresponds to the broadest definition of fragments [28].
MQN-maps produced by principal component analysis
(PCA) of the MQN data and representation of the (PC1,
PC2), (PC1, PC3) and (PC2, PC3) planes illustrate the
structural diversity of PubChem fragments, and how the
subsets of molecules fulfilling the increasingly restrictive
criteria of Lipinski’s ‘‘rule of five’’, Oprea’s ‘‘lead-like-
ness’’ and Congreve’s‘‘rule of three’’ are distributed [29].
We show that MQN-similarity searches allow significant
enrichments for recovering groups of fragment-sized bio-
active compounds related to ten different biological targets
taken from Chembl, while allowing lead-hopping rela-
tionships not seen with substructure fingerprint similarity
Table 1 The 42 Molecular
quantum numbers (MQNs)
a Polarity counts consider the
ionization state predicted for the
physiological pH = 7.4. hbam
counts lone pairs on H-bond
acceptor atoms and hbdm
counts H-atoms on H-bond
donating atoms
b All topology counts refer to
the smallest set of smallest
rings. afr and bfr count atoms
repectively bonds shared by at
least two rings
Atom counts (12) Topology countsb (17)
c Carbon asv Acyclic monovalent nodes
f Fluorine adv Acyclic divalent nodes
cl Chlorine atv Acyclic trivalent nodes
br Bromine aqv Acyclic tetravalent nodes
i Iodine cdv Cyclic divalent nodes
s Sulphur ctv Cyclic trivalent nodes
p Phosphorous cqv Cyclic tetravalent nodes
an Acyclic nitrogen r3 3-Membered rings
cn Cyclic nitrogen r4 4-Membered rings
ao Acyclic oxygen r5 5-Membered rings
co Cyclic oxygen r6 6-Membered rings
hac Heavy atom count r7 7-Membered rings
r8 8-Membered rings
Polarity countsa (6) r9 9-Membered rings
hbam H-bond acceptor sites rg10 C10 Membered rings
hba H-bond acceptor atoms afr Atoms shared by fused rings
hbdm H-bond donor sites bfr Bonds shared by fused rings
hbd H-bond donor atoms
neg Negative charges
pos Positive charges
Bond counts (7)
asb Acyclic single bonds
adb Acyclic double bonds
atb Acyclic triple bonds
csb Cyclic single bonds
cdb Cyclic double bonds
ctb Cyclic triple bonds
rbc Rotatable bond count
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searches. Finally, the MQN-distance histograms of com-
pound series in MQN-space are proposed as a measure for
their structural diversity.
Results and discussion
The fragment subset of PubChem
The public database PubChem archives the molecular
structures and bioassay data within the National Institute of
Health (NIH) Roadmap for Medical Research Initiative.
Among the 49,792,078 entries (December 20, 2010),
4,512,612 compounds had up to 20 non-hydrogen atoms
(hac B 20), which corresponds to the broadest definition of
fragments [28]. From these compounds, 4,383,087 (97%)
also fulfilled Lipinski’s ‘‘rule of five’’ (Ro5) criteria for
bioavailability [30], 3,243,980 (72%) fulfilled Oprea’s
criteria for lead-likeness (LL) [31], 1,604,411 (36%) ful-
filled Congreve’s ‘‘rule of 3’’ for fragment-likeness (Ro3)
[32], and 616,677 (14%) had further restrictions in rotat-
able bonds (rbc B 3) and polar surface area (PSA B 60
A˚2) (Ro3?). The distribution of the compounds according
to the molecular properties is shown as histograms in
Fig. 1. MQNs were computed for these compounds as
previously described, [11, 27] giving a total of 2,357,293
unique MQN-combinations, or ‘‘MQN-bins’’, of which
1,602,337 are occupied by a single molecule. The most
occupied MQN-bin contains 270 compounds (Table 2;
Fig. 2).
Visualisation
PCA of the MQN data showed that the first three principal
components covered 86% of the variance (Fig. 3). The first
principal component PC1 (38% of variance) corresponded
mostly to the fraction of cyclic atoms per molecule, with
strong positive loadings in cyclic single bonds (csb) and
cyclic divalent atoms (cdv), and strong negative loadings in
acyclic single bonds (asb). PC2 (25% of variance) repre-
sented molecular size and flexibility, with strong positive
loadings in heavy atom count (hac), carbon count (c),
acyclic single bonds (asb) and rotatable bond count (rbc).
Finally PC3 (12% of variance) represented polarity, with
strong positive loadings in hydrogen bond acceptors (hbam
and hba) and negative loadings in carbon count (c).
Color-coded maps were constructed from the MQN data
in form of the projections in the (PC1, PC2), (PC1, PC3)
and (PC2, PC3) planes (Fig. 4). The occupancy maps
showed that the fragments were distributed in a series of
parallel islands in the (PC1, PC2) and (PC1, PC3) planes,
corresponding to an increasing number of rings per mole-
cule in accordance with the loadings of PC1. Each of these
islands was occupied by smaller, rigid molecules at low
PC2 values, and larger, more flexible molecules at high
PC2 values. The highest occupancy corresponded to
Fig. 1 Property histograms of Pubchem subsets: hac B 20 (blue
line), Ro5 (green line), LL (yellow line), Ro3 (dashed red line) and
Ro3? (red line). a Molecular weight. b H-bond acceptor atom count.
c. H-bond donor atom count. d Calculated water-octanol partition
coefficient. e Rotabable bond count. f Polar surface area
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monocyclic and bicyclic molecules with 12–18 heavy
atoms and 1–3 H-bond donor atoms in a region mostly
occupied by the lead-like compounds. The Ro5, lead-like
and Ro3 compounds were most clearly separated in the
(PC2, PC3) projection spreading compounds according to
Table 2 MQN-statistics for PubChem fragments and subsets
Subseta cpds MQN-binsb MQN-binswith 1 cpd MQN-bin occupancy
Max. Average
All 4,512,570 2,357,293 1,602,337 270 1.91 ± 2.77
Ro5 4,383,087 2,296,292 1,561,555 270 1.96 ± 2.77
LL 3,243,980 1,797,684 1,246,420 269 1.91 ± 2.75
Ro3 1,604,441 819,422 541,952 269 1.80 ± 2.40
Ro3? 661,677 362,670 245,247 112 1.82 ± 2.15
a All: PubChem hacB 20, Ro5: Lipinski’s bioavailable, LL: Oprea’s lead-like, Ro3: Congreve’s fragment-like, Ro3?: Congreve’s fragment-like
including rbc B 3 and PSA B 60 A˚
´ 2
b Number of unique combinations in the 42-dimensional MQN-system. See also legend of Fig. 3 for exhaustive listing of the MQNs
Fig. 2 Distribution of MQN-bins as a function of bin-occupancy for
the PubChem fragments. See Table 1 for subset definition
Fig. 3 Loading plots in the PCA of the MQN data of PubChem fragments. The 42 MQNs are defined in Table 1
Fig. 4 Projections of the MQN-space of PubChem fragments in the
(PC1, PC2) plane (left), (PC1, PC3) plane (center), and (PC2, PC3)
plane (right). The maps are color-coded for the indicated values and
subsets. The projections were obtained by hasing the surface on
1,000 9 800 pixels ((PC1,PC2) and (PC1,PC3)) and 800 9 800
pixels (PC2,PC3). a Each pixel is colored using the hue as indication
for the occupancy in a continuous range from blue (1) to red (200). b–
d Pixels, representing a set of molecules, are colored using the hue for
the average value and saturation to grey for standard deviation (50%
saturation = 10% standard deviation) for the corresponding value.
e The pixels are colored using red, yellow, green and violet for each
of the fragment types. Saturation to grey was used to indicate the
purity for the dominant fragment type
c
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size and polarity, in agreement with the criteria employed
in these increasingly restrictive subsets.
Virtual screening in MQN-space
If a chemical space is relevant to medicinal chemistry,
nearest neighbours in that chemical space should share
similar bioactivities. This hypothesis can be tested by
measuring the recovery from a database of a family of
molecules active on the same target by sorting the database
by increasing distance to a reference compound for that
target. The recovery of x% of the actives after searching
y% of the distance-sorted database should be multiplied by
an enrichment factor EFy = x%/y% significantly larger
than one, with maximum possible values EF0.1 = 1,000
and EF1 = 100. The distance measure between molecules
may be the euclidean distance satisfying the triangular
inequality, [13] or a variety of other similarity measures
[33]. We showed previously that high EFs are obtained for
recovering bioactives of the DUD database [26] from the
entire PubChem database using either the city-block dis-
tance CBDMQN or the Tanimoto similarity coefficient
TMQN as distance measure. The EFs derived the MQN-
values were comparable to those obtained using the cor-
responding similarity measures CBDSF and TSF derived
from a daylight-type 1,024-bit substructure fingerprint
(SF), however the MQN-similarity searches allowed for
interesting lead-hopping enrichments not seen using SF-
similarity [27].
To test if similar EFs might be possible within the more
restricted fragment subset of PubChem, EFs were com-
puted for ten groups of fragment-sized molecules
(hac B 20) collected from the Chembl database with
reported activity on ten drug targets [34]. The value IC50 or
EC50 B 10 lM was chosen as activity threshold for frag-
ment-type activity [28]. The ten targets were associated
with nine drugs belonging to the 200 top-selling drugs in
2010. The entire PubChem fragment subset and its Ro5,
LL, Ro3 and Ro3? subsets as discussed above were sorted
by similarity to the compound closest to the mathematical
center of gravity in MQN-space (cgMQN) for each group.
Sorting was performed with the four similarity measures
CBDMQN, TMQN, CBDSF and TSF (Tables 3, 4; Fig. 5).
The best EFs for recovering actives from the corre-
sponding PubChem subset were obtained from SF-simi-
larity searching, reflecting the fact that many compound
series were developed by variations on conserved scaf-
folds. The enrichments from MQN-similarity searching
were however also very significant, indicating that com-
pounds with similar bioactivities tend to be relatively close
to one another in MQN-space at the size of fragments.
Remarkably, the top-scoring analogs found by MQN-sim-
ilarity searching included many analogs with very low
substructure similarity as measured by SF. This confirms
our previous observation with the DUD-actives that
searching by MQN-similarity allows for lead-hopping
relationships. On the other hand analogs picked by SF
similarity also showed a good level of MQN similarity
(Fig. 5, right scatter plots, Fig. 6) [27].
MQN-distance histograms as diversity measure
Estimating the diversity of a compound collection in the
perspective of its potential value for bioactivity is a diffi-
cult problem to which various solutions have been pro-
posed [16, 35, 36], in particular extended-connectivity
fingerprints (ECFP) [37]. The MQN-system offers an
attractive alternative to appreciate structural diversity, even
if quite simple in comparison of the existing methods. One
may consider any compound series as a cloud in MQN-
space around its mathematical centre of gravity (cgMQN).
The diversity then can be characterized by a histogram of
Table 3 Drug targets from Chembl used for virtual screening
Target Codea Bioactivesb Drug Codea Hac
Cyclooxygenase-2 (COX2) 230 351 Diclofenac 139 19
Voltage-Gated Ca2? channel a2/d subunit 1 1919 43 Gabapentin 940 12
Beta-1 adrenergic receptor 213 84 Metoprolol 13 19
Na? channel protein type II asubunit 3399 25 Oxcarbazepine 1068 19
Dopamine D1 Receptor 2056 48 Ropinirole 589 19
Na-dependent serotonin transporter 228 562 Sertraline 809 20
Na-dependent dopamine transporter 338 392 Sertraline 809 20
Tyrosine-protein kinase ABL1 1862 35 Temozolomide 810 14
b-glucocerebrosidase 2179 25 Voglibose 476960 18
Farnesyl diphosphate synthase 1782 91 Zolderonic acid 924 16
a Chembl code listed in the Chembl database (www.ebi.ac.uk/chembl/)
b Compounds listed with IC50 or EC50 B 10 lM for the indicated targets were considered as bioactives. The bioactives include compounds with
polypharmacology
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Table 4 Enrichment of bioactive compounds from the PubChem fragmentsa
Drug target Subsetb Act. CBDMQN TMQN CBDSF TSF
EF0.1 EF1 EF0.1 EF1 EF0.1 EF1 EF0.1 EF1
Cyclooxygenase-2 (COX2) All 351 12 13 16 22 71 18 84 23
Ro5 309 9 11 9 21 60 19 71 22
LL 137 15 8 38 11 30 13 34 14
Ro3 65 12 3 41 11 25 8 25 10
Ro3? 39 89 23 149 37 79 13 79 18
Voltage-Gated Ca2? channel a2/d subunit 1 All 43 442 47 442 44 744 91 907 98
Ro5 43 442 47 442 44 744 91 907 98
LL 43 419 47 395 44 744 91 814 95
Ro3 43 419 44 395 44 721 91 721 95
Ro3? 6 1,000 100 833 100 833 100 1,000 100
b-1 adrenergic receptor All 84 60 20 95 21 405 68 488 70
Ro5 84 60 20 95 21 405 68 488 70
LL 82 49 21 98 22 402 68 488 70
Ro3 61 164 16 164 16 246 62 262 61
Ro3? 13 615 62 538 62 615 62 615 62
Na? channel protein type II a subunit All 25 240 24 240 28 400 48 360 52
Ro5 23 261 26 261 30 435 52 391 57
LL 13 462 46 462 54 769 92 692 92
Ro3 13 462 46 462 54 692 85 692 92
Ro3? 9 333 67 667 67 1,000 100 1,000 100
Dopamine D1 Receptor All 48 63 27 167 29 167 35 146 58
Ro5 48 63 27 167 29 167 35 146 58
LL 39 77 31 103 31 231 36 179 82
Ro3 38 53 26 105 32 79 34 132 58
Ro3? 6 333 33 333 33 333 83 833 100
Na-dependent serotonin transporter All 562 14 7 63 19 23 6 20 7
Ro5 549 16 7 71 22 26 6 23 7
LL 263 15 1 15 4 22 4 22 9
Ro3 244 31 3 31 8 31 6 31 5
Ro3? 101 26 5 26 5 26 8 26 3
Na-dependent dopamine transporter All 392 99 32 156 32 306 44 352 47
Ro5 388 101 32 157 32 309 44 356 47
LL 209 72 25 120 27 268 52 359 55
Ro3 199 15 20 111 24 256 45 322 54
Ro3? 127 32 9 94 21 55 32 55 57
Tyrosine-protein kinase ABL1 All 35 86 11 86 9 114 23 200 31
Ro5 35 86 11 86 9 114 23 200 31
LL 22 91 14 91 9 136 27 227 36
Ro3 5 400 40 400 40 600 60 600 60
Ro3? 4 500 50 500 50 500 50 500 50
b-Glucocerebrosidase All 25 400 60 480 60 880 88 880 96
Ro5 17 412 53 412 41 824 82 824 94
LL 17 412 53 353 41 824 82 824 94
Farnesyl diphosphate synthase All 91 462 64 462 58 143 60 165 44
Ro5 91 462 64 462 58 143 60 154 42
LL 91 429 64 462 58 143 60 154 42
a Enrichment factors (EF) for recovery of the indicated number of actives (act.) from the indicated subset using various similarity measures relative to the
compound closest to the respective MQN-center of gravity (cgMQN) as reference bioactive compound
b Subsets from which the actives are recovered: all: PubChem hacB20, 4,512,612 cpds, Ro5: Lipinski’s bioavailable, 4,383,087 cpds, LL: Oprea’s lead-like,
3,243,980 cpds, Ro3: Congreve’s fragment-like, 1,604,411 cpds, Ro3?: Congreve’s fragment-like including rbcB3 and PSA B 60 A˚
´ 2, 616,677 cpds. See also text
and Fig. 5
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CBDMQN to the cgMQN. Large average CBDMQN from the
cgMQN indicate diversity, while shorter average distances
indicate similarity of the compound series in MQN-space.
In this analysis, the PubChem fragments and the Ro3
and Ro3? subsets showed a gaussian type distance distri-
bution with most compounds located at 15 \ CBDMQN
\ 45 from their cgMQN (Fig. 7a). Two series of 20k com-
pounds following the restricted Congreve’s rule taken
randomly from PubChem compounds (Ro3? cpds) or
MQN-bins (Ro3? bins) had distance histograms essen-
tially matching that of the entire Ro3? PubChem subset. A
similarly sized commercial fragment library selected for
diversity had somewhat shorter CBDMQN, with most
compounds located at 12 \ CBDMQN \ 35, and almost no
compounds at CBDMQN [ 50 from their cgMQN (Fig. 7b).
The ten bioactive series from Chembl were focused around
their respective cgMQN with a sharp peak at CBDMQN = 21
(Fig. 7c, dashed line). The narrower distribution of bioac-
tives around their cgMQN was in line with the virtual
screening results above, illustrating further that sets of
compounds active on the same target are relatively close to
one another in MQN-space, and therefore somewhat less
MQN-diverse compared to random series.
The MQN-diversity of known drugs was analyzed next.
From the 6,716 drugs registered in the DrugBank, 472 fol-
lowed the Ro3? fragment-likeness rule, an additional 564
followed Ro3, and an additional 1,550 were within hac B
20. Most Ro3 ? drugs were located at 15 \CBDMQN \ 45
from their cgMQN, most Ro3 drugs were located at 25 \
CBDMQN \ 50 from their cgMQN, and most hac B 20 drugs
were located at 25 \ CBDMQN \ 55 from their cgMQN
(Fig. 7c). Thus, known drugs covered a range of MQN-space
comparable to the entire PubChem fragments.
To estimate how closely the three 20k fragment series
introduced above approached the MQN-space of the known
drugs, the shortest CBDMQN of each drug to each complete
series was calculated. In the resulting shortest CBDMQN
histograms, high values indicated drugs whose MQN-space
environment was not covered by a 20k fragment series. The
analysis showed that each 20 k series contained com-
pounds at short CBDMQN to all Ro3? drugs, with most
shortest CBDMQN \ 15 for the commercial fragment
library and most CBDMQN \ 10 for the two random series
(red line in Fig. 7d–f). The three 20k series also had
compounds within CBDMQN \ 40 of the vast majority of
Ro3 drugs (blue line in Fig. 7d–f) and hac B 20 drugs
(black line in Fig. 7d–f), an MQN-distance which is
compatible with sharing a similar bioactivity.
The distribution of compounds in MQN-space was further
characterized by histograms of exhaustive pairwise
CBDMQN, which can be computed in reasonable time for
small series up to a few thousand compounds. Pairwise
CBDMQN covered all values up to 127 for hac B 20 drugs
and up to 90 for Ro3 and Ro3? drugs, showing that known
drugs covered a broad range of MQN-space (Fig. 7g). The
value range for the three 20k series was comparable to that of
the Ro3? drugs, again with a somewhat narrower range for
the commercial series (Fig. 7h). On the other hand the
pairwise CBDMQN within the ten Chembl bioactive series
were significantly shorter and peaked at CBDMQN = 25–30,
with almost no values above 60, illustrating once more that
compounds of similar activity are relatively close to one
another in MQN-space (Fig. 7j). However the scatter of
pairwise CBDMQN was relatively large, as could be expected
since CBDMQN cannot be the only determinant of biological
activity.
Conclusion
The 4.5 million fragment-sized molecules in PubChem were
analyzed using the MQN-system, revealing the spread of
structural diversity across compounds with various number
of ring atoms, size, and polarity. Pubchem appeared to be
particularly rich in monocyclic and bicyclic molecules of
15–18 heavy atoms with 1–3 H-bond donor atoms, corre-
sponding to lead-like structures according to Oprea. Com-
pounds active on the same target were relatively close to one
another in MQN-space. This was illustrated by the signifi-
cant enrichments when recovering bioactives from ten bio-
activity classes from Chembl by MQN-similarity searches,
and by the narrower distance histogram of these bioactivity
classes for compared to randomly selected compounds. The
fragments of PubChem and their different subsets can be
explored by CBDMQN similarity searching using a PubChem
browser application available at www.gdb.unibe.ch.
Methods
Pubchem
Pubchem was downloaded on December 20, 2010. The
library was reduced by allowing a maximum of 20 non-
hydrogen atoms (hac B 20). The library was additionally
restricted by only keeping molecules with the elements H,
B, C, N, O, F, P, S, Cl, Br and I, while conserving at least
Fig. 5 Enrichment curves for recovering drugs and their bioactive
analogs in Table 3 from the Pubchem hac B 20 subset (all, 4,512,612
cpds) by sorting relative to the bioactive compound closest to cgMQN
using CBDMQN (thick black line), TMQN (thin black line), CBDSF
(thick grey line), or TSF (thin grey line) as similarity measure. The
scatter plots at right show the pairs of similarity values for the
bioactives of all ten targets recovered by MQN (upper two scatter
plots) and SF similarity (lower two scatter plots) after screening 0.1%
(red), 1% (orange), 10% (green) and 100% (blue) of the sorted
PubChem hac B 20 subset
b
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one carbon in each molecule. Fragments from entries with
multiple molecules were treated as different fragments.
Positive and negative charges were neutralised, whenever
possible. Finally the library was cleaned to contain unique
fragments only. Final library size is 4,512,612 entries.
MQNs
MQNs were calculated using the previously reported cal-
culator source code (Supporting Information in Ref. [11])
written in Java using the JChem library from Chemaxon,
Ltd. Prior to MQN-calculation, the ionization state of each
structure was adjusted to pH 7.4 using the JChem API.
Principal component analysis (PCA)
PCA was programmed in Java JDK 1.6 using the JSci
science API. PCA was following the steps as described in
the turotial of Lindsay I Smith (www.cs.otago.ac.nz/cosc
453/student_tutorials/principal_components.pdf).
Chembl bioactives
Bioactives for each of the ten targets (Table 2) were
downloaded from the Chembl website (www.ebi.ac.uk/
chembl). The bioactives were restricted to a maximum of
20 non-hydrogen atoms and keeping only entries with the
elements H, B, C, N, O, F, P, S, Cl, Br and I, while con-
serving at least one carbon in each molecule.
Drugbank fragment library
Drugbank was downloaded on February 1, 2011 from
www.drugbank.ca/system/downloads/. The original library
of 6,716 molecules was reduced by allowing a maximum
size of 20 non-hydrogen atoms (hac B 20). The library was
further restricted by allowing only atoms of type H, B, C,
N, O, F, P, S, Cl, Br and I, while conserving at least one
carbon in each molecule. The final library contained 2,586
molecules.
Subsets
All applied subsets filters were programmed in Java using
JChem 5.2.6 of Chemaxon Ltd. (www.chemaxon.com).
Lipinski ‘‘rule of 5’’ (Ro5) had following cutoff values:
MW B 500, clogP B 5, H-bond acceptors B 10 and
H-bond donors B 5. Cutoff values for lead-like filter (LL):
MW B 350, clogP B 3, H-bond acceptors B 10 and
H-bond donors B 5. Cutoff values for Congreve ‘‘rule of
3’’ (Ro3): MW B 300, H-bond donors B 3 and H-bond
acceptors B 3. More restricted ‘‘rule of 3’’ (Ro3?) used
the following additional criteria to the Ro3: rotatable bond
count (rbc) B 3 and PSA B 60 A˚
´ 2.
City-block-distance
An object A is defined by means of vector XA of n attributes
such that XA ¼ x1A; x2A; . . .; xjA; . . .; xnA
 
. For two objects
A and B, desribed by means of vector XA and XB with n
elements, the city-block-distance (CBDA,B), also known as
Hamming distance or Manhattan distance, is defined as the
sum of the absolute difference for each value [38] j:
CBDA;B ¼
Xn
j¼1
xjA  xjB
  ð1Þ
Tanimoto similarity coefficient
The Tanimoto similarity coefficient (TA,B), also known as
Jaccard coefficient, for two objects A and B, represented by
means of vector XA and XB with length n and attributes j, is
calculated using the following formula [38]:
TA;B ¼
Pn
j¼1 xjA  xjB
Pn
j¼1 xjA
 2 þPnj¼1 xjB
 2 Pnj¼1 xjA  xjB
ð2Þ
Center of gravity
The center of gravity (cgMQN) for a dataset was calculated
down the column to produce a new 42-dimensional MQN,
composed of the mean value for each descriptor.
Enrichments
For enrichment each set of bioactives was diluted into the
corresponding subset of Pubchem. The molecule closest to
the mathematical center of gravity in the 42-dimensional
MQN-space (cgMQN) was chosen as bait molecule for the
distance and similarity calculations using either molecular
quantum numbers (MQN) or a Daylight-type 1024 sub-
structure fingerprint (SF). The list of molecules was then
sorted according to the shortest CBDMQN or CBDSF and
highest TMQN or TSF.
Fig. 6 Structural formulae of drugs and analogs. cgMQN indicates the
compound that is closest to the mathematical centre of gravity in the
42-dimensional MQN-system for each of the corresponding Chembl
bioactive series (see Table 3). The compound following each cgMQN
are lead-hopping examples of analogs that are similar by MQN
similarity measures (CBDMQN or TMQN) and dissimilar by substruc-
ture fingerprint similarity measures (CBDSF or TSF)
b
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Fig. 7 a–e CBDMQN-distance histograms. Follow main text for a
detailed discussion of each pannel. ‘‘20 k random Ro3?
cpds’’=20,000 cpds taken randomly from the Ro3? subset of
PubChem, ‘‘20 k random Ro3? bins’’=20,000 cpds taken from
20,000 bins choosen at random from all MQN-bins occupied by the
Ro3? subset of PubChem. ‘‘10 Chembl sets’’=all compounds in the
10 bioactive series of Table 3 relative to their respective cgMQN.
Drugbank compounds: there are 1,550 drugs in DrugBank with
hac B 20 NOT Ro3, 564 drugs with Ro3 NOT Ro3?, and 472 drugs
following Ro3?. In the Chembl sets hac B 20, there are 988
bioactives from hac B 20 NOT Ro3, 363 bioactives from Ro3 NOT
Ro3? and 305 bioactives from Ro3?. In Fig. 7j, pairwise distances
were only measured within sets of actives for the same target. In
Figure g–j, identity pairs are excluded
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Glossary
CBDMQN City-block distance in MQN-space. Values
are positive integers with small numbers
indicating high similarity
CBDSF City-block distance in substructure-fin-
gerprint space. Values are positive integers
with small numbers indicating high similarity
cgMQN Center of gravity of a compound series in
MQN-space. 42-line vector composed of the
42 average values of the MQNs calculated
across the compound series
LL Subset of PubChem hac \ 20 following
Oprea’s criteria for lead-likeness
MQN Molecular Quantum Numbers. A set of 42
integer value descriptors of molecular
structure. See Legend of Fig. 3 for detailed
listing
MQN-bin A position in MQN-space corresonding to a
particular combination of 42 MQN-values.
An MQN-bin may contain one or several
molecules
MQN-space 42-dimensional space created by the MQNs
Ro3 Subset of PubChem hac \ 20 following
Congreve’s ‘‘rule of 3’’ for fragment-
likeness
Ro3? Subset of Ro3 with further restrictions in
rotatable bonds (rbc B 3) and polar surface
area (PSA B 60 A˚2)
Ro5 Subset of the PubChem hac B 20 following
Lipinski’s ‘‘rule of 5’’
SF Substructure fingerprint. Here the 1024-bit
Daylight-type substructure fingerprint in the
JChem package of ChemAxon was used
TMQN Scalar Tanimoto similarity coefficient
comparing two scalar vectors of 42 MQN-
values. Values between 0 and 1 with 1
indicating high similarity
TSF Binary Tanimoto similarity coefficient
comparing two binary substructure finger-
prints. Values between 0 and 1 with 1
indicating high similarity
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